HEADER MENU Contacto Search SEARCH ACERCA DE PFIZER LISTA DE PRECIOS Innovaciones que cambian las vidas de los pacientes . MAIN NAVIGATION ACERCA DE PFIZER LISTA DE PRECIOS TERMS & POLICIES TÉRMINOS Y CONDICIONES DE USO COPYRIGHT © 2019 PFIZER VENEZUELA, S.A., TODOS LOS DERECHOS RESERVADOS.- PROHIBIDA SU REPRODUCCION TOTAL O PARCIAL SIN AUTORIZACION DE SU TITULAR. LAS MARCAS UTILIZADAS EN EL PRESENTE DOCUMENTO SON MARCAS REGISTRADAS EN FAVOR DE SU TITULAR. Venezuela PP-PFE-COL-1446 Our site uses cookies and other similar technologies to tailor your experience and understand how you and other visitors use our site. For more information and to set your cookie preferences, please visit our Cookie Consent Tool . Otherwise, if you agree to our use of cookies, please continue to use our site. I agree

ABOUT PFIZER ADVERSE EVENT REPORTING English WELCOME TO PFIZER SAUDI LIMITED CORPORATE WEBSITE PFIZER IS A RESEARCH BASED GLOBAL BIOPHARMACEUTICAL COMPANY THAT ENGAGED IN THE DISCOVERY, DEVELOPMENT & MANUFACTURING OF HEALTHCARE PRODUCTS Pfizer is a research based global biopharmaceutical company that engaged in the discovery, development & manufacturing of healthcare products that includes medicines and vaccines to improve patient’s lives. It has been operating in Saudi Arabia since early 1960s. And it has a portfolio in different therapeutic areas include internal medicines, vaccines, oncology, inflammation & Immunolog... FIND OUT MORE PFIZER IN SAUDI ARABIA SIGNED A MEMORANDUM OF UNDERSTANDING WITH THE SAUDI ARABIAN GENERAL INVESTMENT AUTHORITY In October 2011, Pfizer in Saudi Arabia signed a memorandum of understanding with the Saudi Arabian General Investment Authority (SAGIA) to set up its first ever manufacturing plant throughout the GCC in King Abdullah Economic City in Saudi Arabia & kicked off the construction of its new manufacturing plant in February 2013. The full manufacturing & packaging was completed by 2017. FIND OUT MORE MAKING PFIZER THE FIRST PHARMACEUTICAL MULTINATIONAL COMPANIES WAS AWARDED SUCH A LICENSE On June 22, 2016 SAGIA issued a “trading license” to Pfizer, making Pfizer the first pharmaceutical multinational companies was awarded such a license. The new license, which is effective immediately, gives Pfizer “100 percent foreign ownership” of its legal entity in Saudi Arabia with the ability to import, export, and trade in wholesale and retail products, equipment, and instruments. ... FIND OUT MORE THE TOTAL NUMBER OF 4.4 MILLION PATIENTS IN SAUDI ARABIA BENEFITED FROM PFIZER’S INNOVATIVE AND DIVERSIFIED THERAPIES DURING 2019. The total number of 4.4 Million patients in Saudi Arabia benefited from Pfizer’s innovative and diversified therapies during 2019. Additionally, Pfizer Saudi Vaccines had helped in protection of more than 5 million children in Saudi Arabia from serious infections of invasive and mucosal pneumococcal disease during the last 12 years, and continue to provide innovation in the immunization ... FIND OUT MORE Terms of Use Privacy Policy Copyright © 2020 Pfizer Saudi Limited Corporate. All rights reserved.